Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to NAFLD-related liver cirrhosis and is a main cause of chronic liver diseases. Patients with nonalcoholic steatohepatitis and fibrosis are at a great risk of the progression to cirrhosis or hepatocellular carcinoma, both of which...
Saved in:
Cover
Loading…
Abstract | Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to NAFLD-related liver cirrhosis and is a main cause of chronic liver diseases. Patients with nonalcoholic steatohepatitis and fibrosis are at a great risk of the progression to cirrhosis or hepatocellular carcinoma, both of which are tightly associated with liver-related mortality. Liver biopsy is still the gold standard for the diagnosis of NAFLD, but some defects, such as serious complications, sampling error and variability in histologic evaluation among pathologists, remain problematic. Therefore, noninvasive, repeatable and accurate diagnostic methods are urgently needed. Ultrasonography is a well-established and lower-cost imaging technique for the diagnosis of hepatic steatosis, especially suitable for population census, but limited by its low sensitivity to diagnose mild steatosis and being highly operator-dependent. Computed tomography also lacks the sensitivity to detect mild steatosis and small changes in fat content, and presents a potential radiation hazard. Controlled attenuation parameter based on the FibroScan
technology is a promising tool for noninvasive semiquantitative assessment of liver fat content, but the accuracy rate depends on the operator's expertise and is affected by age, width of the intercostal space, skin capsular distance and body mass index. Magnetic resonance imaging and magnetic resonance spectroscopy are regarded as the most accurate quantitative methods for measuring liver fat content in clinical practice, especially for longitudinal follow up of NAFLD patients. In this review, we mainly introduce the current imaging methods that are in use for evaluation of liver fat content and we discuss the advantages and disadvantages of each method. |
---|---|
AbstractList | Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to NAFLD-related liver cirrhosis and is a main cause of chronic liver diseases. Patients with nonalcoholic steatohepatitis and fibrosis are at a great risk of the progression to cirrhosis or hepatocellular carcinoma, both of which are tightly associated with liver-related mortality. Liver biopsy is still the gold standard for the diagnosis of NAFLD, but some defects, such as serious complications, sampling error and variability in histologic evaluation among pathologists, remain problematic. Therefore, noninvasive, repeatable and accurate diagnostic methods are urgently needed. Ultrasonography is a well-established and lower-cost imaging technique for the diagnosis of hepatic steatosis, especially suitable for population census, but limited by its low sensitivity to diagnose mild steatosis and being highly operator-dependent. Computed tomography also lacks the sensitivity to detect mild steatosis and small changes in fat content, and presents a potential radiation hazard. Controlled attenuation parameter based on the FibroScan
®
technology is a promising tool for noninvasive semiquantitative assessment of liver fat content, but the accuracy rate depends on the operator’s expertise and is affected by age, width of the intercostal space, skin capsular distance and body mass index. Magnetic resonance imaging and magnetic resonance spectroscopy are regarded as the most accurate quantitative methods for measuring liver fat content in clinical practice, especially for longitudinal follow up of NAFLD patients. In this review, we mainly introduce the current imaging methods that are in use for evaluation of liver fat content and we discuss the advantages and disadvantages of each method. Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to NAFLD-related liver cirrhosis and is a main cause of chronic liver diseases. Patients with nonalcoholic steatohe-patitis and fibrosis are at a great risk of the progression to cirrhosis or hepatocellular carcinoma, both of which are tightly associated with liver-related mortality. Liver biopsy is still the gold standard for the diagnosis of NAFLD, but some defects, such as serious complications, sampling error and variability in histologic evaluation among pathologists, remain problematic. Therefore, noninvasive, repeatable and accurate diagnostic methods are urgently needed. Ultrasonography is a well-established and lower-cost imaging technique for the diagnosis of hepatic steatosis, especially suitable for population census ,but limited by its low sensitivity to diagnose mild steatosis and being highly operator-dependent. Computed tomography also lacks the sensitivity to detect mild steatosis and small changes in fat content, and presents a potential radiation hazard. Controlled attenuation parameter based on the FibroScan? technology is a promising tool for noninvasive semiquantita-tive assessment of liver fat content, but the accuracy rate de-pends on the operator's expertise and is affected by age, width of the intercostal space, skin capsular distance and body mass index. Magnetic resonance imaging and magnetic resonance spectroscopy are regarded as the most accurate quantitative methods for measuring liver fat content in clinical practice, especially for longitudinal follow up of NAFLD patients. In this review, we mainly introduce the current imaging methods that are in use for evaluation of liver fat content and we discuss the advantages and disadvantages of each method. Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to NAFLD-related liver cirrhosis and is a main cause of chronic liver diseases. Patients with nonalcoholic steatohepatitis and fibrosis are at a great risk of the progression to cirrhosis or hepatocellular carcinoma, both of which are tightly associated with liver-related mortality. Liver biopsy is still the gold standard for the diagnosis of NAFLD, but some defects, such as serious complications, sampling error and variability in histologic evaluation among pathologists, remain problematic. Therefore, noninvasive, repeatable and accurate diagnostic methods are urgently needed. Ultrasonography is a well-established and lower-cost imaging technique for the diagnosis of hepatic steatosis, especially suitable for population census, but limited by its low sensitivity to diagnose mild steatosis and being highly operator-dependent. Computed tomography also lacks the sensitivity to detect mild steatosis and small changes in fat content, and presents a potential radiation hazard. Controlled attenuation parameter based on the FibroScan technology is a promising tool for noninvasive semiquantitative assessment of liver fat content, but the accuracy rate depends on the operator's expertise and is affected by age, width of the intercostal space, skin capsular distance and body mass index. Magnetic resonance imaging and magnetic resonance spectroscopy are regarded as the most accurate quantitative methods for measuring liver fat content in clinical practice, especially for longitudinal follow up of NAFLD patients. In this review, we mainly introduce the current imaging methods that are in use for evaluation of liver fat content and we discuss the advantages and disadvantages of each method. |
Author | Xuan, Shiying Jiang, Sushan Dong, Quanjiang Lv, Shujing Xin, Yongning Liu, Shousheng |
AuthorAffiliation | Medical College of Qingdao University, Qingdao, Shandong, China%Digestive Disease Key Laboratory of Qingdao, Qingdao, Shandong, China;Central Laboratories, Qingdao Municipal Hospital, Qingdao, Shandong, China%Central Laboratories, Qingdao Municipal Hospital, Qingdao, Shandong, China;Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China%Medical College of Qingdao University, Qingdao, Shandong, China;Digestive Disease Key Laboratory of Qingdao, Qingdao, Shandong, China;Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China;Department of Infectious Disease, Qingdao Municipal Hospital, Qingdao, Shandong, China%Medical College of Qingdao University, Qingdao, Shandong, China;Digestive Disease Key Laboratory of Qingdao, Qingdao, Shandong, China;Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China |
AuthorAffiliation_xml | – name: Medical College of Qingdao University, Qingdao, Shandong, China%Digestive Disease Key Laboratory of Qingdao, Qingdao, Shandong, China;Central Laboratories, Qingdao Municipal Hospital, Qingdao, Shandong, China%Central Laboratories, Qingdao Municipal Hospital, Qingdao, Shandong, China;Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China%Medical College of Qingdao University, Qingdao, Shandong, China;Digestive Disease Key Laboratory of Qingdao, Qingdao, Shandong, China;Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China;Department of Infectious Disease, Qingdao Municipal Hospital, Qingdao, Shandong, China%Medical College of Qingdao University, Qingdao, Shandong, China;Digestive Disease Key Laboratory of Qingdao, Qingdao, Shandong, China;Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China |
Author_xml | – sequence: 1 givenname: Shujing surname: Lv fullname: Lv, Shujing organization: Medical College of Qingdao University, Qingdao, Shandong, China – sequence: 2 givenname: Sushan surname: Jiang fullname: Jiang, Sushan organization: Medical College of Qingdao University, Qingdao, Shandong, China – sequence: 3 givenname: Shousheng surname: Liu fullname: Liu, Shousheng organization: Central Laboratories, Qingdao Municipal Hospital, Qingdao, Shandong, China – sequence: 4 givenname: Quanjiang surname: Dong fullname: Dong, Quanjiang organization: Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China – sequence: 5 givenname: Yongning surname: Xin fullname: Xin, Yongning organization: Department of Infectious Disease, Qingdao Municipal Hospital, Qingdao, Shandong, China – sequence: 6 givenname: Shiying surname: Xuan fullname: Xuan, Shiying organization: Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29951367$$D View this record in MEDLINE/PubMed |
BookMark | eNpVUU1v1DAQtVARLaV3TihHDs0ythMnviChLf1ACwipnC3HmWy8ytoldhbt_nq8H1QgS2OP3pvnmXmvyZnzDgl5S2FGC0brDysT-xkDWs8AgNEX5IJxCnldU3mW3oyVOVRUnpOrEFaJQksKQsIrcs6kLCkX1QUx37yzbqOD3WD2Y9Iu2qjjPrnBiCZa77KvGHvfhsx32SIhY3arYzb3LqKLmXVZktCD8b0frNljcXvi3diAOuAb8rLTQ8Cr031Jft5-fpzf54vvdw_zT4vcFFLGnGpDhWyKVpQl6hrapmKtoQ2IVnbSUNlKOByuq65tQPOG8bIqOCKXggt-ST4edZ-mZo2tSe2NelBPo13rcau8tup_xNleLf1GibRDDmUSuD4K_Nau026pVn4a02xBDWa765fNbqdwv3BIgSf6-9N_o_81YYhqbYPBYdAO_RQUA0ELqFnBEhWOVDP6EEbsnruioA5uqi_zx3u1F1cHN1PJu3-neS746x3_Azehnhk |
CitedBy_id | crossref_primary_10_1097_MCG_0000000000001380 crossref_primary_10_12998_wjcc_v10_i25_8906 crossref_primary_10_20340_vmi_rvz_2024_1_MIM_2 crossref_primary_10_3390_diagnostics11050842 crossref_primary_10_1007_s12072_023_10576_z crossref_primary_10_1111_tri_13823 crossref_primary_10_1080_17474124_2019_1608820 crossref_primary_10_1111_ijcp_13635 crossref_primary_10_1016_j_diabres_2020_108458 crossref_primary_10_1155_2022_7073647 crossref_primary_10_1002_jmri_27292 crossref_primary_10_1016_j_jceh_2020_11_004 crossref_primary_10_1177_2050312120933804 crossref_primary_10_3390_nu14112223 crossref_primary_10_1155_2019_9047324 crossref_primary_10_1177_20420188221106879 crossref_primary_10_1186_s13098_020_00558_8 crossref_primary_10_3389_fped_2021_784221 crossref_primary_10_3390_nu14173462 crossref_primary_10_1007_s00261_021_03225_2 crossref_primary_10_3390_jcm7120528 crossref_primary_10_1364_BOE_413712 crossref_primary_10_3390_nu12040891 crossref_primary_10_4103_sjg_sjg_484_22 crossref_primary_10_3389_fmed_2021_615978 crossref_primary_10_3390_diagnostics11112137 crossref_primary_10_1007_s11901_018_0421_y crossref_primary_10_1186_s13098_023_01033_w crossref_primary_10_25259_GJMPBU_63_2022 crossref_primary_10_1097_MEG_0000000000001461 |
Cites_doi | 10.1016/j.acra.2012.05.009 10.1016/j.jhep.2015.11.004 10.1111/j.1478-3231.2012.02781.x 10.1007/s10334-013-0414-3 10.1177/0284185115580488 10.1002/jmri.25006 10.3748/wjg.v20.i16.4702 10.1007/s00261-012-9930-2 10.1002/mrm.26028 10.1002/jmri.24568 10.1016/j.jhep.2015.10.009 10.1111/liv.12809 10.3748/wjg.v21.i21.6736 10.1002/hep.26455 10.3851/IMP2228 10.1016/j.mri.2016.05.007 10.1002/hep.27666 10.1016/j.jhep.2013.12.018 10.1002/jmri.22701 10.1002/mrm.24923 10.1007/s10620-017-4638-3 10.1053/j.gastro.2015.11.048 10.1002/hep.28699 10.2337/dc14-1239 10.1016/j.crad.2015.10.002 10.1259/bjr.20150117 10.3748/wjg.v22.i39.8812 10.1186/s12916-014-0137-y 10.1111/j.1651-2227.2007.00399.x 10.1002/hep.28012 10.1136/gutjnl-2011-300342 10.1007/s00247-014-3024-y 10.1111/hepr.12767 10.1186/s13052-014-0084-4 10.1002/hep.27368 10.1111/j.1478-3231.2012.02820.x 10.1111/hepr.12330 10.1111/hepr.12649 10.1148/radiol.13121360 10.5152/dir.2015.14331 10.2214/AJR.11.7384 |
ContentType | Journal Article |
Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. 2018 Authors. 2018 |
Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. – notice: 2018 Authors. 2018 |
DBID | NPM AAYXX CITATION 7X8 2B. 4A8 92I 93N PSX TCJ 5PM |
DOI | 10.14218/jcth.2018.00021 |
DatabaseName | PubMed CrossRef MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Lv S. et al: Liver fat content detection methods |
EISSN | 2310-8819 |
EndPage | 221 |
ExternalDocumentID | lcyzhgbzz_e201802013 10_14218_JCTH_2018_00021 29951367 |
Genre | Journal Article Review |
GrantInformation_xml | – fundername: This study was supported by a grant from the National Natural Science Foundation of China funderid: (31770837) |
GroupedDBID | 4.4 92I 93N ADRAZ ALMA_UNASSIGNED_HOLDINGS DIK EBS EJD FRP HYE KQ8 M48 MET M~E NPM OK1 PGMZT RPM TCJ TGQ WFFXF AAYXX CITATION 7X8 2B. 4A8 92F PSX 5PM |
ID | FETCH-LOGICAL-c499t-1ac169b4d655ea80db72dc1b06d9f9c19d90909093a7fdb0a3b235743ee396363 |
IEDL.DBID | RPM |
ISSN | 2225-0719 |
IngestDate | Tue Sep 17 21:17:11 EDT 2024 Wed Nov 06 04:25:26 EST 2024 Fri Aug 16 20:58:35 EDT 2024 Fri Aug 23 01:14:12 EDT 2024 Wed Oct 16 00:58:27 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 2 |
Keywords | Nonalcoholic fatty liver disease Hydrogen-1 magnetic resonance spectroscopy Liver fat content Noninvasive |
Language | English |
License | This article has been published under the terms of Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which permits noncommercial unrestricted use, distribution, and reproduction in any medium, provided that the following statement is provided. “This article has been published in Journal of Clinical and Translational Hepatology at DOI: 10.14218/JCTH.2018.00021 and can also be viewed on the Journal’s website at http://www.jcthnet.com”. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c499t-1ac169b4d655ea80db72dc1b06d9f9c19d90909093a7fdb0a3b235743ee396363 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Study concept and design (SjL, SJ, YX), acquisition of data (SjL, SJ, SsL, QD), drafting of the manuscript (SjL, SJ), critical revision of the manuscript for important intellectual content (YX), study supervision (SX). The authors have no conflict of interests related to this publication. These two authors contributed equally to this work. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018305/ |
PMID | 29951367 |
PQID | 2061408242 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6018305 wanfang_journals_lcyzhgbzz_e201802013 proquest_miscellaneous_2061408242 crossref_primary_10_14218_JCTH_2018_00021 pubmed_primary_29951367 |
PublicationCentury | 2000 |
PublicationDate | 2018-Jun-28 |
PublicationDateYYYYMMDD | 2018-06-28 |
PublicationDate_xml | – month: 06 year: 2018 text: 2018-Jun-28 day: 28 |
PublicationDecade | 2010 |
PublicationPlace | China |
PublicationPlace_xml | – name: China |
PublicationTitle | Journal of clinical and translational hepatology |
PublicationTitleAlternate | J Clin Transl Hepatol |
PublicationTitle_FL | Journal of Clinical and Translational Hepatology |
PublicationYear | 2018 |
Publisher | Medical College of Qingdao University, Qingdao, Shandong, China%Digestive Disease Key Laboratory of Qingdao, Qingdao, Shandong, China Central Laboratories, Qingdao Municipal Hospital, Qingdao, Shandong, China%Central Laboratories, Qingdao Municipal Hospital, Qingdao, Shandong, China Digestive Disease Key Laboratory of Qingdao, Qingdao, Shandong, China Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China%Medical College of Qingdao University, Qingdao, Shandong, China Department of Infectious Disease, Qingdao Municipal Hospital, Qingdao, Shandong, China%Medical College of Qingdao University, Qingdao, Shandong, China XIA & HE Publishing Inc |
Publisher_xml | – name: Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China – name: Digestive Disease Key Laboratory of Qingdao, Qingdao, Shandong, China – name: Central Laboratories, Qingdao Municipal Hospital, Qingdao, Shandong, China%Central Laboratories, Qingdao Municipal Hospital, Qingdao, Shandong, China – name: Department of Infectious Disease, Qingdao Municipal Hospital, Qingdao, Shandong, China%Medical College of Qingdao University, Qingdao, Shandong, China – name: Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, China%Medical College of Qingdao University, Qingdao, Shandong, China – name: Medical College of Qingdao University, Qingdao, Shandong, China%Digestive Disease Key Laboratory of Qingdao, Qingdao, Shandong, China – name: XIA & HE Publishing Inc |
References | 25399407 - Ital J Pediatr. 2014 Nov 17;40:84 27351583 - Hepatol Res. 2017 Apr;47(5):455-464 22766513 - Antivir Ther. 2012;17(6):965-71 26201284 - J Magn Reson Imaging. 2016 Feb;43(2):398-406 24446249 - J Magn Reson Imaging. 2014 Aug;40(2):251-68 24178986 - MAGMA. 2014 Aug;27(4):317-27 21846782 - Gut. 2012 Mar;61(3):409-15 24378529 - J Hepatol. 2014 May;60(5):1026-31 22736224 - Abdom Imaging. 2013 Apr;38(2):315-9 24840769 - Pediatr Radiol. 2014 Nov;44(11):1379-87 27818597 - World J Gastroenterol. 2016 Oct 21;22(39):8812-8819 28577247 - Dig Dis Sci. 2017 Sep;62(9):2569-2577 26074712 - World J Gastroenterol. 2015 Jun 7;21(21):6736-44 26677985 - Gastroenterology. 2016 Mar;150(3):626-637.e7 27062661 - J Hepatol. 2016 Jun;64(6):1388-402 25833350 - Br J Radiol. 2015 Jun;88(1050):20150117 27211257 - Magn Reson Imaging. 2016 Oct;34(8):1114-20 22435761 - Liver Int. 2012 Jul;32(6):902-10 21769986 - J Magn Reson Imaging. 2011 Oct;34(4):928-34 23382293 - Radiology. 2013 Jun;267(3):767-75 24782622 - World J Gastroenterol. 2014 Apr 28;20(16):4702-11 23696515 - Hepatology. 2013 Dec;58(6):1930-40 26588040 - Magn Reson Med. 2016 Nov;76(5):1400-1409 26627137 - Diagn Interv Radiol. 2016 Jan-Feb;22(1):13-21 22841289 - Acad Radiol. 2012 Oct;19(10):1208-14 26471505 - J Hepatol. 2016 Feb;64(2):308-315 24636073 - Hepatol Res. 2014 Dec;44(14):E420-7 25529941 - Hepatology. 2015 Jun;61(6):1887-95 25125077 - Hepatology. 2015 May;61(5):1547-54 27183219 - Hepatol Res. 2016 Sep;46(10):1019-27 25855666 - Acta Radiol. 2016 Mar;57(3):271-8 26555703 - Clin Radiol. 2016 Jan;71(1):58-63 24006275 - Magn Reson Med. 2014 Aug;72(2):510-21 22733887 - AJR Am J Roentgenol. 2012 Jul;199(1):2-7 27338123 - Hepatology. 2016 Dec;64(6):2234-2243 22672642 - Liver Int. 2012 Jul;32(6):911-8 26224591 - Hepatology. 2015 Nov;62(5):1444-55 25689614 - Liver Int. 2015 Nov;35(11):2392-400 17655622 - Acta Paediatr. 2007 Aug;96(8):1209-13 25887357 - Diabetes Care. 2015 Jul;38(7):1347-55 25164060 - BMC Med. 2014 Aug 26;12:137 Bazick (key20180622033329_b3) 2015; 38 Fujimori (key20180622033329_b28) 2016; 46 de Lédinghen (key20180622033329_b29) 2017; 62 Arboleda (key20180622033329_b32) 2016; 76 Ekstedt (key20180622033329_b6) 2015; 61 Sagi (key20180622033329_b19) 2007; 96 Takatsu (key20180622033329_b38) 2015; 88 Guaraldi (key20180622033329_b22) 2012; 17 Chabanova (key20180622033329_b36) 2013; 38 Deng (key20180622033329_b4) 2014; 44 Kan (key20180622033329_b11) 2014; 44 Soliman (key20180622033329_b14) 2014; 72 de Lédinghen (key20180622033329_b25) 2014; 60 Jiménez-Agüero (key20180622033329_b10) 2014; 12 Imajo (key20180622033329_b2) 2016; 150 Schwimmer (key20180622033329_b9) 2015; 61 Idilman (key20180622033329_b7) 2013; 267 Zhang (key20180622033329_b17) 2015; 21 Wong (key20180622033329_b21) 2012; 61 Di Martino (key20180622033329_b18) 2016; 22 Fischer (key20180622033329_b39) 2012; 19 Hayashi (key20180622033329_b35) 2017; 47 Noureddin (key20180622033329_b20) 2013; 58 Heba (key20180622033329_b41) 2016; 43 Kłusek-Oksiuta (key20180622033329_b12) 2014; 40 Kang (key20180622033329_b13) 2011; 34 de Lédinghen (key20180622033329_b24) 2012; 32 Georgoff (key20180622033329_b40) 2012; 199 Shen (key20180622033329_b30) 2015; 35 Hannah (key20180622033329_b1) 2016; 64 EASL-EASD-EASO (key20180622033329_b15) 2016; 64 Eggers (key20180622033329_b31) 2014; 40 Shen (key20180622033329_b27) 2014; 20 Myers (key20180622033329_b26) 2012; 32 Runge (key20180622033329_b33) 2014; 27 Keese (key20180622033329_b23) 2016; 22 Lee (key20180622033329_b37) 2016; 34 Bannas (key20180622033329_b5) 2015; 62 Krishan (key20180622033329_b16) 2016; 71 Pavlides (key20180622033329_b8) 2016; 64 Idilman (key20180622033329_b34) 2016; 57 |
References_xml | – volume: 19 start-page: 1208 year: 2012 ident: key20180622033329_b39 article-title: Liver fat quantification by dual-echo MR imaging outperforms traditional histopathological analysis publication-title: Acad Radiol doi: 10.1016/j.acra.2012.05.009 contributor: fullname: Fischer – volume: 64 start-page: 1388 year: 2016 ident: key20180622033329_b15 article-title: Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease publication-title: J. Hepatol doi: 10.1016/j.jhep.2015.11.004 contributor: fullname: EASL-EASD-EASO – volume: 32 start-page: 902 year: 2012 ident: key20180622033329_b26 article-title: Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography publication-title: Liver Int doi: 10.1111/j.1478-3231.2012.02781.x contributor: fullname: Myers – volume: 27 start-page: 317 year: 2014 ident: key20180622033329_b33 article-title: Measuring liver triglyceride content in mice: non-invasive magnetic resonance methods as an alternative to histopathology publication-title: MAGMA doi: 10.1007/s10334-013-0414-3 contributor: fullname: Runge – volume: 57 start-page: 271 year: 2016 ident: key20180622033329_b34 article-title: A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease publication-title: Acta Radiol doi: 10.1177/0284185115580488 contributor: fullname: Idilman – volume: 43 start-page: 398 year: 2016 ident: key20180622033329_b41 article-title: Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference publication-title: J Magn Reson Imaging doi: 10.1002/jmri.25006 contributor: fullname: Heba – volume: 20 start-page: 4702 year: 2014 ident: key20180622033329_b27 article-title: Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients publication-title: World J Gastroenterol doi: 10.3748/wjg.v20.i16.4702 contributor: fullname: Shen – volume: 38 start-page: 315 year: 2013 ident: key20180622033329_b36 article-title: (1)H MRS assessment of hepatic steatosis in overweight children and adolescents: comparison between 3T and open 1T MR-systems publication-title: Abdom Imaging doi: 10.1007/s00261-012-9930-2 contributor: fullname: Chabanova – volume: 76 start-page: 1400 year: 2016 ident: key20180622033329_b32 article-title: Total liver fat quantification using three-dimensional respiratory self-navigated MRI sequence publication-title: Magn Reson Med doi: 10.1002/mrm.26028 contributor: fullname: Arboleda – volume: 40 start-page: 251 year: 2014 ident: key20180622033329_b31 article-title: Chemical shift encoding-based water-fat separation methods publication-title: J Magn Reson Imaging doi: 10.1002/jmri.24568 contributor: fullname: Eggers – volume: 64 start-page: 308 year: 2016 ident: key20180622033329_b8 article-title: Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2015.10.009 contributor: fullname: Pavlides – volume: 35 start-page: 2392 year: 2015 ident: key20180622033329_b30 article-title: Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease publication-title: Liver Int doi: 10.1111/liv.12809 contributor: fullname: Shen – volume: 21 start-page: 6736 year: 2015 ident: key20180622033329_b17 article-title: 3.0T 1H magnetic resonance spectroscopy for assessment of steatosis in patients with chronic hepatitis C publication-title: World J Gastroenterol doi: 10.3748/wjg.v21.i21.6736 contributor: fullname: Zhang – volume: 58 start-page: 1930 year: 2013 ident: key20180622033329_b20 article-title: Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials publication-title: Hepatology doi: 10.1002/hep.26455 contributor: fullname: Noureddin – volume: 17 start-page: 965 year: 2012 ident: key20180622033329_b22 article-title: Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities publication-title: Antivir Ther doi: 10.3851/IMP2228 contributor: fullname: Guaraldi – volume: 34 start-page: 1114 year: 2016 ident: key20180622033329_b37 article-title: Fat fraction estimation of morphologically normal lumbar vertebrae using the two-point mDixon turbo spin-echo MRI with flexible echo times and multipeak spectral model of fat: Comparison between cancer and non-cancer patients publication-title: Magn Reson Imaging doi: 10.1016/j.mri.2016.05.007 contributor: fullname: Lee – volume: 61 start-page: 1887 year: 2015 ident: key20180622033329_b9 article-title: Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease publication-title: Hepatology doi: 10.1002/hep.27666 contributor: fullname: Schwimmer – volume: 60 start-page: 1026 year: 2014 ident: key20180622033329_b25 article-title: Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations publication-title: J Hepatol doi: 10.1016/j.jhep.2013.12.018 contributor: fullname: de Lédinghen – volume: 34 start-page: 928 year: 2011 ident: key20180622033329_b13 article-title: Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms publication-title: J Magn Reson Imaging doi: 10.1002/jmri.22701 contributor: fullname: Kang – volume: 72 start-page: 510 year: 2014 ident: key20180622033329_b14 article-title: Max-IDEAL: a max-flow based approach for IDEAL water/fat separation publication-title: Magn Reson Med doi: 10.1002/mrm.24923 contributor: fullname: Soliman – volume: 62 start-page: 2569 year: 2017 ident: key20180622033329_b29 article-title: Controlled attenuation parameter (CAP) with the XL probe of the Fibroscan®: A comparative study with the M probe and liver biopsy publication-title: Dig Dis Sci doi: 10.1007/s10620-017-4638-3 contributor: fullname: de Lédinghen – volume: 150 start-page: 626 year: 2016 ident: key20180622033329_b2 article-title: Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.11.048 contributor: fullname: Imajo – volume: 64 start-page: 2234 year: 2016 ident: key20180622033329_b1 article-title: Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.28699 contributor: fullname: Hannah – volume: 38 start-page: 1347 year: 2015 ident: key20180622033329_b3 article-title: Clinical model for NASH and advanced fibrosis in adult patients with diabetes and NAFLD: Guidelines for referral in NAFLD publication-title: Diabetes Care doi: 10.2337/dc14-1239 contributor: fullname: Bazick – volume: 71 start-page: 58 year: 2016 ident: key20180622033329_b16 article-title: Non-invasive quantification of hepatic steatosis in living, related liver donors using dual-echo Dixon imaging and single-voxel proton spectroscopy publication-title: Clin Radiol doi: 10.1016/j.crad.2015.10.002 contributor: fullname: Krishan – volume: 88 start-page: 20150117 year: 2015 ident: key20180622033329_b38 article-title: The Dixon technique and the frequency-selective fat suppression technique in three-dimensional T1 weighted MRI of the liver: a comparison of contrast-to-noise ratios of hepatocellular carcinomas-to-liver publication-title: Br J Radiol doi: 10.1259/bjr.20150117 contributor: fullname: Takatsu – volume: 22 start-page: 8812 year: 2016 ident: key20180622033329_b18 article-title: Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents publication-title: World J Gastroenterol doi: 10.3748/wjg.v22.i39.8812 contributor: fullname: Di Martino – volume: 12 start-page: 137 year: 2014 ident: key20180622033329_b10 article-title: Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery publication-title: BMC Med doi: 10.1186/s12916-014-0137-y contributor: fullname: Jiménez-Agüero – volume: 96 start-page: 1209 year: 2007 ident: key20180622033329_b19 article-title: Nonalcoholic fatty liver disease in overweight children and adolescents publication-title: Acta Paediatr doi: 10.1111/j.1651-2227.2007.00399.x contributor: fullname: Sagi – volume: 62 start-page: 1444 year: 2015 ident: key20180622033329_b5 article-title: Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers publication-title: Hepatology doi: 10.1002/hep.28012 contributor: fullname: Bannas – volume: 61 start-page: 409 year: 2012 ident: key20180622033329_b21 article-title: Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography publication-title: Gut doi: 10.1136/gutjnl-2011-300342 contributor: fullname: Wong – volume: 44 start-page: 1379 year: 2014 ident: key20180622033329_b4 article-title: Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease publication-title: Pediatr Radiol doi: 10.1007/s00247-014-3024-y contributor: fullname: Deng – volume: 47 start-page: 455 year: 2017 ident: key20180622033329_b35 article-title: Hepatic fat quantification using the two-point Dixon method and fat color maps based on non-alcoholic fatty liver disease activity score publication-title: Hepatol Res doi: 10.1111/hepr.12767 contributor: fullname: Hayashi – volume: 40 start-page: 84 year: 2014 ident: key20180622033329_b12 article-title: Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children publication-title: Ital J Pediatr doi: 10.1186/s13052-014-0084-4 contributor: fullname: Kłusek-Oksiuta – volume: 61 start-page: 1547 year: 2015 ident: key20180622033329_b6 article-title: Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up publication-title: Hepatology doi: 10.1002/hep.27368 contributor: fullname: Ekstedt – volume: 32 start-page: 911 year: 2012 ident: key20180622033329_b24 article-title: Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography publication-title: Liver Int doi: 10.1111/j.1478-3231.2012.02820.x contributor: fullname: de Lédinghen – volume: 44 start-page: E420 year: 2014 ident: key20180622033329_b11 article-title: Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease publication-title: Hepatol Res doi: 10.1111/hepr.12330 contributor: fullname: Kan – volume: 46 start-page: 1019 year: 2016 ident: key20180622033329_b28 article-title: Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis publication-title: Hepatol Res doi: 10.1111/hepr.12649 contributor: fullname: Fujimori – volume: 267 start-page: 767 year: 2013 ident: key20180622033329_b7 article-title: Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy publication-title: Radiology doi: 10.1148/radiol.13121360 contributor: fullname: Idilman – volume: 22 start-page: 13 year: 2016 ident: key20180622033329_b23 article-title: In vivo and ex vivo measurements: noninvasive assessment of alcoholic fatty liver using 1H-MR spectroscopy publication-title: Diagn Interv Radiol doi: 10.5152/dir.2015.14331 contributor: fullname: Keese – volume: 199 start-page: 2 year: 2012 ident: key20180622033329_b40 article-title: Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosis publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.11.7384 contributor: fullname: Georgoff |
SSID | ssj0001510690 |
Score | 2.2904582 |
SecondaryResourceType | review_article |
Snippet | Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to NAFLD-related liver cirrhosis and is a main cause of chronic liver diseases. Patients... |
SourceID | pubmedcentral wanfang proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 217 |
SubjectTerms | Review |
SummonAdditionalLinks | – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS8MwEA-iCL6I4tf8IoI--FBt2rRdH0REHUN0IDjwLSRpogPJ1HXq9td7l3bq0AfpU8kRwi93vbveFyH74JiYVDEWmIjrgFsOMmebLMiLJLOSJ1wpjOjedNJ2l1_dJ_ff5dE1gIM_XTucJ9V9fTr6eBmdgsCfoMBzUFHHV-d3bczSwrTIEKvK5yIOfjom8tXGflUzzLAtL06bAybGyp28jlv-tcm0nvplfP7OoZx_l85K9_BDPbWWyGJtV9KzihGWyYxxK0R38Gfrm8QUdXo7lM5XlOHLhSl9DpajN36E9ID2Lb3GHA3akiX1PatcSXuOdtBU92N0exrXylFNd1GFdlZJt3V5d94O6qkKgQbvpgyY1CzNFS_SJDGyGRYqiwrNVJgWuc01y4s89E8sM1uoUMYKW-Lw2JgYpDWN18is6zuzQSi41UWc6dT6xmshXKvVkTSpBs3LtIwa5HCCoXiummcIdDoQb4F4C8RbeLwbZG8CsgAOx7CFdKY_HAANmBBgqXDYb70C_Ws3UKYJNp1rkGzqOr4IsHv29IrrPfou2uCJNuFj1yAH9cWJCfOJJz0aPz6o8VgYPCBY1Cze_Mf5tsgC0mMmWdTcJrPl69DsgM1Sql3Pip-0xun7 priority: 102 providerName: Scholars Portal |
Title | Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29951367 https://search.proquest.com/docview/2061408242 https://d.wanfangdata.com.cn/periodical/lcyzhgbzz-e201802013 https://pubmed.ncbi.nlm.nih.gov/PMC6018305 |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED6awqAvo2Vbl3UtGmwPe3Bj2fKvx5I2hLKEDVrom5BkqQ20Slmcjeav351sl5S-DT8ZCVncnbg736fvAL5iYmJzzXlkE2Ei4QSeOVfyqKqzwimRCa2pojub59NrcXmT3exA1t-FCaB9oxen_v7h1C_uArby8cGMepzY6OdsjElEiXY6GsAADXQrRW-vBnNi36WmcmirdEGn6sqTAt3Z6HJ8NSVEF0Eo0b8RGXCFUUYaGs1veaZX4eZr1OSbv8o75W-3HNJkH952kSQ7a3d8ADvWvwMzp9-rfxSB0tmvtfLhDhm9nNsmoK48m4Wm0Su2dOwHoTLYRDUssFT5hi08m1NwHhrnLgyNNU_dvPO2mPMericXV-Np1PVRiAzmM03EleF5pUWdZ5lVZVzrIqkN13FeV64yvKqrODypKlytY5VqIsERqbUpns88_QC7funtR2CYSNdpYXIXqNZiVKQzibK5QV_LjUqG8L2XoXxs6TIkpRkkekmilyR6GUQ_hC-9kCXaNBUqlLfL9QrnYNCAsYnA9Q5boT-v1mtrCMULdTxPIL7slyNoRoE3uzObIXzrFCe787qS9-Zpc3erNxtpaYMYQ_P0039_4Qj2aBVClCXlZ9htfq_tMcYujT6BwUyUJ8Fi_wElBu7v |
link.rule.ids | 230,315,730,783,787,888,2228,24330,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED-6jrG9jI59Zes2DbaHPbixbNmOH0fakHVJ2CCFvglJltpAq5TFaWn--t7Jdknp2_CTkZDFfXB3vt_dAXzDwMTmmvPIJsJEwgnUOTfgUVllhVMiE1pTRnc6y8cn4vg0O92BrKuFCaB9oxcH_uLywC_OA7by6tL0O5xY_890iEHEAOW0_wSeor7GYitIb4qDOfXfpbFyKK1UolO2CUqBBq1_PJyPCdNFIEq0cNQOuEQ_Iw2j5rds0yOH8zFu8tmN8k75sy2TNNqDl60vyX42d34FO9a_BjOjH6zXimDp7O9a-VBFRi-Htg64K8-mYWz0ii0dmxAug41UzUKfKl-zhWczcs_D6NyFobX6tt132KRz3sDJ6Gg-HEftJIXIYERTR1wZnpdaVHmWWTWIK10kleE6zqvSlYaXVRmHJ1WFq3SsUk1tcERqbYoamqdvYdcvvX0PDEPpKi1M7kKztRhZ6UyibG7Q2nKjkh786Ggor5qGGZICDSK9JNJLIr0MpO_B147IEqWaUhXK2-V6hXvQbUDvROB57xqi35_WcasHxQN23G-gjtkPV1CQQufsVnB68L1lnGw1diUvzO3m_ExvNtLSBdGL5umH__7CF3g-nk8ncvJr9vsjvKATCV-WDPZht_63tp_Qk6n15yC3dz9s8Ws |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdbx8ZeRse-0n1psD3swbVly3L8OJKGrGtCBy30TeizDbRKaJyW5q_fneyUlL4NPxkJWZzuuN_5froj5DsEJk5oxhKXc5Nwz8HmfJ8ltS0rr3jJtcaM7mQqxqf88Kw822r1FUn7Rs_2w-XVfphdRG7l4sqkG55YejwZQBDRBz1NF9anT8kzsNlMbAXq7QVhhjV4sbUcaCxe06m7JCUHp5YeDk7GyOtCIiV4OSwJXAPWKGK7-S3_9Ah0PuZOPr9VwatwvuWWRrvkVYcn6a9236_JExfeEDPFn6w3Cqnp9O9KhXiTDF-Groncq0AnsXX0ks49PUJuBh2phsZaVaGhs0CnCNFj-9yZwbHmrps3bFM6b8np6OBkME66bgqJgaimSZgyTNSaW1GWTvUzq6vcGqYzYWtfG1bbOotPoSpvdaYKjaVweOFcAVYqindkJ8yD-0AohNO2qIzwseBaBsfpTa6cMOBxmVF5j_zcyFAu2qIZEoMNFL1E0UsUvYyi75FvGyFL0GxMV6jg5qslzAHoAAiFw3rvW6Hfr7Y5rR6pHhzH_QSsmv1wBJQpVs_ulKdHfnQHJzurXcpLc7e-ONfrtXS4QUDSrNj77y98JS-OhyN59Hv65yN5iQsixSzvfyI7zfXKfQYw0-gvUW3_AcAB8n4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Noninvasive+Quantitative+Detection+Methods+of+Liver+Fat+Content+in+Nonalcoholic+Fatty+Liver+Disease&rft.jtitle=Journal+of+clinical+and+translational+hepatology&rft.au=Lv%2C+Shujing&rft.au=Jiang%2C+Sushan&rft.au=Liu%2C+Shousheng&rft.au=Dong%2C+Quanjiang&rft.date=2018-06-28&rft.issn=2225-0719&rft.volume=6&rft.issue=2&rft.spage=217&rft.epage=221&rft_id=info:doi/10.14218%2FJCTH.2018.00021&rft.externalDBID=NO_FULL_TEXT |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcyzhgbzz-e%2Flcyzhgbzz-e.jpg |